Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 8, 2014.
November 10, 2014
Share
From August 8, 2014 to September 30, 2014, the company has repurchased 47,307 shares, representing 0.27% for KRW 616.95 million. With this, the company has completed the repurchase of 47,307 shares, representing 0.27% for KRW 616.95 million under the buyback announced on August 8, 2014.
CTCBIO Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals, veterinary drugs, animal feed supplements and functional foods. It pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. It also involves in the development of pharmaceutical manufacturing technology and know-how. The Company distributes its products within domestic market and to overseas markets.
CTCBIO INC. 
